Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLC.

PloS one - 1 Jan 2012

Wang Xiang, Cui Enhai, Zeng Huazong, Hua Feng, Wang Bin, Mao Wei, Feng Xueren

Abstract excerpt

AIM: To explore the association between genetic polymorphisms of the receptor for advanced glycation end-products (RAGE) and susceptibility, chemotherapy response rate and prognosis of non-small cell lung cancer (NSCLC). METHOD: This is a prospective study in which 562 patients with NSCLC and 764 healthy controls were enrolled. Three RAGE genetic polymorphisms, namely, -429T/C, -374T/A and 82G/S were genotyped....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Lung Neoplasms

Share to Organoplatinum Compounds

Share to Prognosis

Share to Receptor for Advanced Glycation End Products

Share to Receptors, Immunologic

Source

Open in PubMed Open full text

Identifiers

PMID: 23071492
DOI: 10.1371/journal.pone.0043734
PMCID: PMC3465300

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLC.PMID 23071492Read ↗

Association of RAGE polymorphisms and cancer risk: a meta-analysis of 27 studies.Semantic proximity Read ↗

Association between the receptor for advanced glycation end products gene polymorphisms and cancer risk: a systematic review and meta-analysis.Semantic proximity Read ↗

Expression of the receptor for advanced glycation end-products and frequency of polymorphism in lung cancerSemantic proximity Read ↗

The genetic variations in DNA repair genes ERCC2 and XRCC1 were associated with the overall survival of advanced non-small-cell lung cancer patients.Semantic proximity Read ↗

The interaction between RAGE gene polymorphisms and HPV infection in determining the susceptibility of cervical cancer in a Chinese population.Semantic proximity Read ↗

DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival.Semantic proximity Read ↗

Polymorphisms of receptor for advanced glycation end products and risk of epithelial ovarian cancer in Chinese patients.Semantic proximity Read ↗

RECK gene polymorphisms influence NSCLC susceptibility, but not the chemotherapy response status in Chinese cohort.Semantic proximity Read ↗

Association of polymorphisms of the receptor for advanced glycation end products gene with COPD in the Chinese population.Semantic proximity Read ↗

Contributory role of five common polymorphisms of RAGE and APE1 genes in lung cancer among Han Chinese.Semantic proximity Read ↗

RAGE may act as a tumour suppressor to regulate lung cancer development.Semantic proximity Read ↗

A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.